ALPHA-2-ADRENOCEPTOR MEDIATED INHIBITION OF EXOCYTOTIC NORADRENALINE RELEASE IN THE ABSENCE OF EXTRACELLULAR CA2+

被引:25
作者
JACKISCH, R [1 ]
HUANG, HY [1 ]
RENSING, H [1 ]
LAUTH, D [1 ]
ALLGAIER, C [1 ]
HERTTING, G [1 ]
机构
[1] CHINESE ACAD SCI,SHANGHAI INST PHYSIOL,SHANGHAI,PEOPLES R CHINA
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1992年 / 226卷 / 03期
关键词
3,4-DIAMINOPYRIDINE; NORADRENALINE RELEASE; HIPPOCAMPUS; CA2+ (INTRACELLULAR); ALPHA-2-ADRENOCEPTOR MECHANISM; (RAT); (RABBIT);
D O I
10.1016/0922-4106(92)90068-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of the alpha-2-adrenoceptor agonist clonidine on 3,4-diaminopyridine (3,4-DAP)-evoked [H-3]noradrenaline ([H-3]NA) release in rat hippocampus slices was studied in the presence or absence (+1 mM EGTA) of extracellular Ca2+. H-3 overflow (consisting mainly of unmetabolized [H-3]NA) was evoked by addition of 100-mu-M 3,4-DAP for 10 min to the medium, which always contained 1-mu-M desipramine. Ligands for L-type voltage-sensitive Ca2+ channels (VSCC) did not affect the evoked [H-3]NA release, whereas the preferential N-type VSCC antagonist omega-conotoxin was inhibitory, both in the presence and even more potently in the absence of Ca2+, suggesting an involvement of N-type VSCC in the mechanism of 3,4-DAP-evoked [H-3]NA release. In the absence of extracellular Ca2+ the initial Na+ influx, which has been previously proposed to liberate Ca2+ from intracellular stores for the exocytotic process, most probably occurs via N-type VSCC. Clonidine inhibited the 3,4-DAP-evoked [H-3]NA release in a concentration-dependent manner, both in the presence and even more potently in the absence of Ca"; its effects were antagonized by yohimbine. In the presence of extracellular Ca2+ the clonidine effect was not changed by addition of omega-conotoxin. Similar effects of clonidine were found in slices from the rabbit hippocampus. Since the availability of Ca2+ from intracellular stores seems to predominate in the present model, our results lend some support to the suggestion that alpha-2-adrenoceptor activation might affect intracellular mechanisms of Ca2+ homeostasis. On the other hand, however, the present data cannot completely exclude that alpha-2-autoreceptor activation leads to opening of presynaptic K+ channels, or that modulation of Ca2+ influx through VSCC is involved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 42 条
[1]   BINDING OF OMEGA-CONOTOXIN TO RECEPTOR-SITES ASSOCIATED WITH THE VOLTAGE-SENSITIVE CALCIUM-CHANNEL [J].
ABE, T ;
KOYANO, K ;
SAISU, H ;
NISHIUCHI, Y ;
SAKAKIBARA, S .
NEUROSCIENCE LETTERS, 1986, 71 (02) :203-208
[2]  
ANDRADE R, 1985, J NEUROSCI, V5, P2359
[3]   CALCIUM-INDEPENDENT RELEASE OF AMINO-ACID NEUROTRANSMITTERS - FACT OR ARTIFACT [J].
BERNATH, S .
PROGRESS IN NEUROBIOLOGY, 1992, 38 (01) :57-91
[4]  
BHAVE SV, 1990, ANN NY ACAD SCI, V604, P188
[5]   OMEGA-CONOTOXIN BLOCKADE DISTINGUISHES CA FROM NA PERMEABLE STATES IN NEURONAL CALCIUM CHANNELS [J].
CARBONE, E ;
LUX, HD .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1988, 413 (01) :14-22
[6]   INHIBITION OF NORADRENALINE RELEASE BY OMEGA-CONOTOXIN GVIA IN THE RAT TAIL ARTERY [J].
CLASBRUMMEL, B ;
OSSWALD, H ;
ILLES, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (01) :101-110
[7]   INTERRELATIONS BETWEEN TRANSPORT OF SODIUM AND CALCIUM IN MITOCHONDRIA OF VARIOUS MAMMALIAN-TISSUES [J].
CROMPTON, M ;
MOSER, R ;
LUDI, H ;
CARAFOLI, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1978, 82 (01) :25-31
[8]   ANALYSIS AND FUNCTIONAL-CHARACTERISTICS OF DIHYDROPYRIDINE-SENSITIVE AND DIHYDROPYRIDINE-INSENSITIVE CALCIUM-CHANNEL PROTEINS [J].
DASCAL, N .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (06) :1171-1178
[9]   INHIBITION OF CENTRAL NEUROTRANSMITTER RELEASE BY OMEGA-CONOTOXIN GVIA, A PEPTIDE MODULATOR OF THE N-TYPE VOLTAGE-SENSITIVE CALCIUM-CHANNEL [J].
DOOLEY, DJ ;
LUPP, A ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 336 (04) :467-470
[10]   OMEGA-CONOTOXIN GVIA AND PHARMACOLOGICAL MODULATION OF HIPPOCAMPAL NORADRENALINE RELEASE [J].
DOOLEY, DJ ;
LUPP, A ;
HERTTING, G ;
OSSWALD, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) :261-267